Truncal Dynamics May Trump: Serial ctDNA to Predict Early Therapeutic Response

Research output: Contribution to journalArticlepeer-review

Abstract

Promising utility of using serial ctDNA in metastatic colorectal cancer to both refine patient selection, reduce toxicity due to chemotherapy, and to evaluate emerging resistance mechanisms may lead the way to novel therapeutic strategies. However, important questions remain in validating its use as a predictive biomarker of treatment response.

Original languageEnglish (US)
Pages (from-to)OF1-OF10
JournalClinical Cancer Research
Volume29
Issue number2
DOIs
StatePublished - Jan 15 2023

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Truncal Dynamics May Trump: Serial ctDNA to Predict Early Therapeutic Response'. Together they form a unique fingerprint.

Cite this